a public good project by the
Synthesis
Company
of California

© 2026

Herbert H. Engelhard | doi.page

0 works0 citations0 h-index

Herbert H. Engelhard

University of Illinois Chicago(US)nanoMAG (United States)(US)

Publications by Year

Research Areas

Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Nanoparticle-Based Drug Delivery, Meningioma and schwannoma management, Cerebrospinal fluid and hydrocephalus

Most-Cited Works

→ Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma(2015)1,203 cited
→ NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality(2012)831 cited
→ Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma(2020)412 cited
→ Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina(2010)219 cited
→ Intramedullary spinal cord tumors: a review of current and future treatment strategies(2015)177 cited
→ Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries(2012)169 cited

→ Malignant pineal germ-cell tumors: An analysis of cases from three tumor registries(2008)143 cited

→ Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe)(2014)143 cited

→ Oligodendroglioma and anaplastic oligodendroglioma:(2003)139 cited

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.(1994)